Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke

International Journal of Cardiology

Volumn 230, Issue , 2017, Pages 577-584

  Muscogiuri, Giovanna ^a   Annweiler, Cedric ^b,c,d   Duval, Guillaume ^b   Karras, Spyridon ^e   Tirabassi, Giacomo ^j   Salvio, Gianmaria ^j   Balercia, Giancarlo ^j   Kimball, Samantha ^f   Kotsa, Kalliopi ^e   Mascitelli, Luca ^g   Bhattoa, Harjit Pal ^h   Colao, Annamaria ⁱ  

^a Ios and Coleman Medicina Futura Medical Center   (Italy)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ D'ANGERS   (France)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e AHEPA UNIVERSITY HOSPITAL   (Greece)

^f Pure North s'Energy Foundation   (Canada)

^g Julia Medical Service   (Italy)

^h UNIVERSITY OF DEBRECEN   (Hungary)

ⁱ UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^j UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

more..

Author keywords

Atherosclerosis; Environment; Lifestyle; Myocardial infarction; Stroke; Vitamin D

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CYCLOOXYGENASE 1; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NITRIC OXIDE; PLACEBO; SOMATOMEDIN C; VITAMIN D; VITAMIN;

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD BRAIN BARRIER; BLOOD FLOW; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; FOAM CELL; HEART INFARCTION; HUMAN; INFLAMMATORY CELL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASODILATATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; COMPLICATION;

ATHEROSCLEROSIS; HUMANS; MYOCARDIAL INFARCTION; STROKE; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 85009282321     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.12.053     Document Type: Review

References (93)

1. [1] Mozaffarian, D., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., Das, S.R., DeFerranti, S., Després, J.P., Fullerton, H.J., et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
2. [2] Holick, M.F., Vitamin, D., Deficiency. N. Engl. J. Med. 357 (2007), 266–281.
3. [3] Falk, E., Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47 (2006), C7–12.
4. [4] Carvalho, L.S., Sposito, A.C., Vitamin D for the prevention of cardiovascular disease: are we ready for that?. Atherosclerosis 241 (2015), 729–740.
5. [5] Nsengiyumva, V., Fernando, M.E., Moxon, J.V., Krishna, S.M., Pinchbeck, J., Omer, S.M., Morris, D.R., Jones, R.E., Moran, C.S., Seto, S.W., Golledge, J., The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: a meta-analysis of observational studies. Atherosclerosis 243 (2015), 645–651.
6. [6] Kunadian, V., Ford, G.A., Bawamia, B., Qiu, W., Manson, J.E., Vitamin, D., Deficiency and coronary artery disease: a review of the evidence. Am. Heart J. 167 (2014), 283–291.
7. [7] Targher, G., Bertolini, L., Padovani, R., Zenari, L., Scala, L., Cigolini, M., Arcaro, G., Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin. Endocrinol. 65 (2006), 593–597.
8. [8] Choi, A.I., Lo, J.C., Mulligan, K., Schnell, A., Kalapus, S.C., Li, Y., Hunt, P.W., Martin, J.N., Deeks, S.G., Hsue, P.Y., Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin. Infect. Dis. 52 (2011), 941–944.
9. [9] van de Luijtgaarden, K.M., Voûte, M.T., Hoeks, S.E., Bakker, E.J., Chonchol, M., Stolker, R.J., Rouwet, E.V., Verhagen, H.J., Vitamin, D., Deficiency may be an independent risk factor for arterial disease. Eur. J. Vasc. Endovasc. Surg. 44 (2012), 301–306.
10. [10] Zagura, M., Serg, M., Kampus, P., Zilmer, M., Eha, J., Unt, E., Lieberg, J., Cockcroft, J.R., Kals, J., Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur. J. Vasc. Endovasc. Surg. 42 (2011), 689–695.
11. [11] Abraham, P.S., Calès, S., Redureau, E., Fantino, B., De Decker, L., Beauchet, O., Annweiler, C., The vitamin “D-bate”: what vascular risk in geriatric inpatients?. J. Am. Geriatr. Soc. 59 (2011), 1556–1558.
12. [12] Razzaque, M.S., The dualistic role of vitamin D in vascular calcifications. Kidney Int. 79 (2011), 708–714.
13. [13] Takeda, M., Yamashita, T., Sasaki, N., Nakajima, K., Kita, T., Shinohara, M., Ishida, T., Hirata, K., Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 2495–2503.
14. [14] Merke, J., Milde, P., Lewicka, S., Hugel, U., Klaus, G., Mangelsdorf, D.J., Haussler, M.R., Rauterberg, E.W., Ritz, E., Identification and regulation of 1.25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1.25 dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J. Clin. Invest. 83 (1989), 1903–1915.
15. [15] Zehnder, D., Bland, R., Chana, R., Synthesis of 1.25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J. Am. Soc. Nephrol. 13 (2002), 621–629.
16. [16] Polidoro, L., Properzi, G., Marampon, F., Gravina, G.L., Festuccia, C., Di Cesare, E., Scarsella, L., Ciccarelli, C., Zani, B.M., Ferri, C., Vitamin, D., Protects human endothelial cells from H₂O₂ oxidant injury through the Mek/Erk-Sirt1 axis activation. J. Cardiovasc. Transl. Res. 6 (2013), 221–231.
17. [17] Strange, R.C., Shipman, K.E., Ramachandran, S., Metabolic syndrome: a review of the role of vitamin D in mediating susceptibility and outcome. World. J. Diabetes 6 (2015), 896–911.
18. [18] Bruno, R.M., Bianchini, E., Faita, F., Taddei, S., Ghiadoni, L., Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc. Ultrasound, 12, 2014, 34.
19. [19] Flammer, A.J., Anderson, T., Celermajer, D.S., Creager, M.A., Deanfield, J., Ganz, P., Hamburg, N.M., Luscher, T.F., Shechter, M., Taddei, S., Vita, J.A., Lerman, A., The assessment of endothelial function: from research into clinical practice. Circulation 126 (2012), 753–767.
20. [20] London, G.M., Guerin, A.P., Verbeke, F.H., Pannier, B., Boutouyrie, P., Marchais, S.J., Metivier, F., Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J. Am. Soc. Nephrol. 18 (2007), 613–620.
21. [21] Chitalia, N., Ismail, T., Tooth, L., Boa, F., Hampson, G., Goldsmith, D., Kaski, J.C., Banerjee, D., Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease. PLoS One, 9, 2014, e91363.
22. [22] Aytaç, M.B., Deveci, M., Bek, K., Kayabey, Ö., Ekinci, Z., Effect of cholecalciferol on local arterial stiffness and endothelial dysfunction in children with chronic kidney disease. Pediatr. Nephrol. 31 (2016), 267–277.
23. [23] Stojanović, M., Radenković, M., Vitamin, D., Versus placebo in improvement of endothelial dysfunction: a meta-analysis of randomized clinical trials. Cardiovasc. Ther. 33 (2015), 145–154.
24. [24] Gepner, A.D., Ramamurthy, R., Krueger, D.C., Korcarz, C.E., Binkley, N., Stein, J.H., A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One, 7, 2012, e36617.
25. [25] Yiu, Y.F., Yiu, K.H., Siu, C.W., Chan, Y.H., Li, S.W., Wong, L.Y., Lee, S.W., Tam, S., Wong, E.W., Lau, C.P., Cheung, B.M., Tse, H.F., Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 227 (2013), 140–146.
26. [26] Zoccali, C., Curatola, G., Panuccio, V., Tripepi, R., Pizzini, P., Versace, M., Bolignano, D., Cutrupi, S., Politi, R., Tripepi, G., Ghiadoni, L., Thadhani, R., Mallamaci, F., Paricalcitol and endothelial function in chronic kidney disease trial. Hypertension 64 (2014), 1005–1011.
27. [27] Radenkovic, M., Stojanovic, M., Potpara, T., Prostran, M., Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art. Biomed. Res. Int., 2013, 2013, 252158.
28. [28] Andrukhova, O., Slavic, S., Zeitz, U., Riesen, S.C., Heppelmann, M.S., Ambrisko, T.D., Markovic, M., Kuebler, W.M., Erben, R.G., Vitamin, D., Is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol. Endocrinol. 28 (2014), 53–64.
29. [29] Singh, R.B., Mengi, S.A., Xu, Y.J., Arneja, A.S., Dhalla, N.S., Pathogenesis of atherosclerosis: a multifactorial process. Exp. Clin. Cardiol. 7 (2002), 40–53.
30. [30] O'Leary, D.H., Bots, M.L., Imaging of atherosclerosis: carotid intima-media thickness. Eur. Heart J. 31 (2010), 1682–1689.
31. [31] Hamdy Al-Said, N., Abd El Ghaffar Mohamed, N., Salam, R.F., Fawzy, M.W., Vitamin D as a risk factor for premature atherosclerosis in patients with type 2 diabetes. Ther. Adv. Endocrinol. Metab. 6 (2015), 249–257.
32. [32] Tessitore, E., Rundek, T., Jin, Z., Homma, S., Sacco, R.L., Di Tullio, M.R., Association between carotid intima-media thickness and aortic arch plaques. J. Am. Soc. Echocardiogr. 23 (2010), 772–777.
33. [33] Melamed, M.L., Muntner, P., Michos, E.D., Uribarri, J., Weber, C., Sharma, J., Raggi, P., Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 1179–1185.
34. [34] Lim, S., Shin, H., Kim, M.J., Ahn, H.Y., Kang, S.M., Yoon, J.W., Choi, S.H., Kim, K.W., Song, J.H., Choi, S.I., Chun, E.J., Shin, C.S., Park, K.S., Jang, H.C., Vitamin, D., Inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean Longitudinal Study on Health and Aging. J. Clin. Endocrinol. Metab. 97 (2012), 169–178.
35. [35] Thiele, I., Linseisen, J., Meisinger, C., Schwab, S., Huth, C., Peters, A., Perz, S., Meitinger, T., Kronenberg, F., Lamina, C., Thiery, J., Koenig, W., Rathmann, W., Kääb, S., Then, C., Seissler, J., Thorand, B., Associations between calcium and vitamin D supplement use as well as their serum concentrations and subclinical cardiovascular disease phenotypes. Atherosclerosis 241 (2015), 743–751.
36. [36] Juonala, M., Voipio, A., Pahkala, K., Viikari, J.S., Mikkilä, V., Kähönen, M., Hutri-Kähönen, N., Jula, A., Burgner, D., Sabin, M.A., Marniemi, J., Loo, B.M., Laitinen, T., Jokinen, E., Taittonen, L., Magnussen, C.G., Raitakari, O.T., Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood. The cardiovascular risk in young Finns study. J. Clin. Endocrinol. Metab. 100 (2015), 1469–1476.
37. [37] Zagami, R.M., Di Pino, A., Urbano, F., Piro, S., Purrello, F., Rabuazzo, A.M., Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c. Atherosclerosis 243 (2015), 395–401.
38. [38] Hao, Y., Ma, X., Luo, Y., Xu, Y., Xiong, Q., Zhu, J., Bao, Y., Jia, W., Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women. PLoS One, 10, 2015, e0122803.
39. [39] Malik, R., Aneni, E.C., Roberson, L., Ogunmoroti, O., Ali, S.S., Shaharyar, S., Younus, A., Jamal, O., Aziz, M.A., Martin, S.S., Blaha, M.J., Feldman, T., Agatston, A.S., Veledar, E., Nasir, K., Measuring coronary artery calcification: is serum vitamin D relevant?. Atherosclerosis 237 (2014), 734–738.
40. [40] Challoumas, D., Stavrou, A., Pericleous, A., Dimitrakakis, G., Effects of combined vitamin D–calcium supplements on the cardiovascular system: should we be cautious?. Atherosclerosis 238 (2015), 388–398.
41. [41] Nicoll, R., McLaren Howard, J., Henein, M.Y., Cardiovascular calcification and bone: a comparison of the effects of dietary and serum calcium, phosphorous, magnesium and vitamin D. International cardiovascular forum. Journal 1 (2014), 209–218.
42. [42] van Dijk, S.C., Sohl, E., Oudshoorn, C., Enneman, A.W., Ham, A.C., Swart, K.M., van Wijngaarden, J.P., Brouwer-Brolsma, E.M., van der Zwaluw, N.L., Uitterlinden, A.G., et al. Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population. Age Ageing 44 (2015), 136–142.
43. [43] Cirillo, M., Bilancio, G., Cirillo, C., Reversible vascular calcifications associated with hypervitaminosis D. J. Nephrol., Aug 30 2015 [Epub ahead of print].
44. [44] Freedman, B.I., Wagenknecht, L.E., Hairston, K.G., Bowden, D.W., Carr, J.J., Hightower, R.C., Gordon, E.J., Xu, J., Langefeld, C.D., Divers, J., Vitamin, D., Adiposity, and calcified atherosclerotic plaque in African-Americans. J. Clin. Endocrinol. Metab. 95 (2010), 1076–1083.
45. [45] Gallagher, J.C., Vitamin, D., Falls — the dosage conundrum. Nat. Rev. Endocrinol. 12 (2016), 680–684.
46. [46] Mendis, S., Abegunde, D., Yusuf, S., Ebrahim, S., Shaper, G., Ghannem, H., Shengelia, B., WHO study on prevention of REcurrences of myocardial infarction and StrokE (WHO-PREMISE). Bull. World Health Organ. 83 (2005), 820–829.
47. [47] Hofmann, U., Frantz, S., Role of T-cells in myocardial infarction. Eur. Heart J., Dec 8 2015 [Epub ahead of print].
48. [48] Kamen, D.L., Tangpricha, V., Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med. (Berl.) 88 (2010), 441–450.
49. [49] Martins, D., Wolf, M., Pan, D., Zadshir, A., Tareen, N., Thadhani, R., Felsenfeld, A., Levine, B., Mehrotra, R., Norris, K., Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 167 (2007), 1159–1165.
50. [50] Nigwekar, S.U., Thadhani, R., Vitamin, D., Receptor activation: cardiovascular and renal implications. Kidney Int. 3 (2013), 427–430.
51. [51] Pilz, S., Tomaschitz, A., Ritz, E., Pieber, T.R., Vitamin D status and arterial hypertension: a systematic review. Nat. Rev. Cardiol. 6 (2009), 621–630.
52. [52] Pham, T.M., Ekwaru, J.P., Loehr, S.A., Veugelers, P.J., The relationship of serum 25-hydroxyvitamin D and insulin resistance among Nondiabetic Canadians: a longitudinal analysis of participants of a preventive health program. PLoS One, 10, 2015, e0141081.
53. [53] Pham, T.M., Ekwaru, J.P., Setayeshgar, S., Veugelers, P.J., The effect of changing serum 25-hydroxyvitamin D concentrations on metabolic syndrome: a longitudinal analysis of participants of a preventive health program. Nutrients 7 (2015), 7271–7284.
54. [54] Pludowski, P., Holick, M.F., Pilz, S., Wagner, C.L., Hollis, B.W., Grant, W.B., Shoenfeld, Y., Lerchbaum, E., Llewellyn, D.J., Kienreich, K., Soni, M., Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun. Rev. 12 (2013), 976–989.
55. [55] Cannell, J.J., Grant, W.B., Holick, M.F., Vitamin D and inflammation. Dermatoendocrinology, 6, 2014, e983401.
56. [56] Satilmis, S., Celik, O., Biyik, I., Ozturk, D., Celik, K., Akin, F., Ayca, B., Yalcin, B., Dagdelen, S., Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population. Bosn. J. Basic Med. Sci. 15 (2015), 67–72.
57. [57] Libby, P., Okamoto, Y., Rocha, V.Z., Folco, E., Inflammation in atherosclerosis: transition from theory to practice. Circ. J. 74 (2010), 213–220.
58. [58] Wang, L., Song, Y., Manson, J.E., Pilz, S., Marz, W., Michaelsson, K., Lundqvist, A., Jassal, S.K., Barrett-Connor, E., Zhang, C., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5 (2012), 819–829.
59. [59] Giovannucci, E., Liu, Y., Hollis, B.W., Rimm, E.B., 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168 (2008), 1174–1180.
60. [60] Brøndum-Jacobsen, P., Benn, M., Jensen, G.B., Nordestgaard, B.G., 25-hydroxyvitamin D levels an risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 2794–2802.
61. [61] Lee, J.H., Gadi, R., Spertus, J.A., Tang, F., O'Keefe, J.H., Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am. J. Cardiol. 107 (2011), 1636–1638.
62. [62] Karur, S., Veerappa, V., Nanjappa, M.C., Study of vitamin D deficiency prevalence in acute myocardial infarction. IJC Heart & Vessels 3 (2014), 57–59.
63. [63] Kuhn, T., Kaaks, R., Teucher, B., Hirche, F., Dierkes, J., Weikert, C., Katzke, V., Boeing, H., Stangl, G.I., Buijsse, B., Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study. PLoS One, 8, 2013, e69080.
64. [64] Karakas, M., Thorand, B., Zierer, A., Huth, C., Meisinger, C., Roden, M., Rottbauer, W., Peters, A., Koenig, W., Herder, C., Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. J. Clin. Endocrinol. Metab. 98 (2013), 272–280.
65. [65] Ford, J.A., MacLennan, G.S., Avenell, A., Bolland, M., Grey, A., Witham, M., RECORD Trial Group, Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am. J. Clin. Nutr. 100 (2014), 746–755.
66. [66] Deleskog, A., Piksasova, O., Silveira, A., Samnegard, A., Tornvall, P., Eriksson, P., Gustafsson, S., Ostenson, C.G., Ohrvik, J., Hamsten, A., Serum 25-hydroxyvitamin D concentration, established and emerging cardiovascular risk factors and risk of myocardial infarction before the age of 60 years. Atherosclerosis 223 (2012), 223–229.
67. [67] Ng, L.L., Sandhu, J.K., Squire, I.B., Davies, J.E., Jones, D.J., Vitamin, D., Prognosis in acute myocardial infarction. Int. J. Cardiol. 168 (2013), 2341–2346.
68. [68] Mao, P.J., Zhang, C., Tang, L., Xian, Y.Q., Li, Y.S., Wang, W.D., Zhu, X.H., Qiu, H.L., He, J., Zhou, Y.H., Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int. J. Cardiol. 169 (2013), 106–111.
69. [69] Heaney, R.P., Toward a physiological referent for the vitamin D requirement. J. Endocrinol. Investig. 37 (2014), 1127–1130.
70. [70] Wrzosek, M., Łukaszkiewicz, J., Wrzosek, M., Jakubczyk, A., Matsumoto, H., Piątkiewicz, P., Radziwoń-Zaleska, M., Wojnar, M., Nowicka, G., Vitamin, D., The central nervous system. Pharmacol. Rep. 65 (2013), 271–278.
71. [71] Brown, J., Bianco, J.I., McGrath, J.J., Eyles, D.W., 1.25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 343 (2003), 139–143.
72. [72] Eyles, D.W., Burne, T.H., McGrath, J.J., Vitamin, D., Effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front. Neuroendocrinol. 34 (2013), 47–64.
73. [73] Eyles, D.W., Smith, S., Kinobe, R., Hewison, M., McGrath, J.J., Distribution of the vitamin D receptor and 1a-hydroxylase in human brain. J. Chem. Neuroanat. 29 (2005), 21–30.
74. [74] Balden, R., Selvamani, A., Sohrabji, F., Vitamin, D., Deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology 153 (2012), 2420–2435.
75. [75] Wang, Y., Chiang, Y.H., Su, T.P., Hayashi, T., Morales, M., Hoffer, B.J., Lin, S.Z., Vitamin D (3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 39 (2000), 873–880.
76. [76] Brewer, L.D., Thibault, V., Chen, K.C., Langub, M.C., Landfield, P.W., Porter, N.M., Vitamin, D., Hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21 (2001), 98–108.
77. [77] Balazs, R., Hack, N., Jorgensen, O.S., Stimulation of the N-methyl-D-aspartate receptor has a trophic effect on differentiating cerebellar granule cells. Neurosci. Lett. 87 (1988), 80–86.
78. [78] Fu, J., Xue, R., Gu, J., Xiao, Y., Zhong, H., Pan, X., Ran, R., Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus. Mol. Med. Rep. 8 (2013), 1708–1714.
79. [79] Won, S., Sayeed, I., Peterson, B.L., Wali, B., Kahn, J.S., Stein, D.G., Vitamin D prevents hypoxia/reoxygenation-induced blood brain barrier disruption via vitamin D receptor-mediatedNF-kB signaling pathways. PLoS One, 10, 2015, e0122821.
80. [80] Brøndum-Jacobsen, P., Nordestgaard, B.G., Schnohr, P., Benn, M., 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann. Neurol. 73 (2013), 38–47.
81. [81] Chowdhury, R., Stevens, S., Ward, H., Chowdhury, S., Sajjad, A., Franco, O.H., Circulating vitamin D, calcium and risk of cerebrovascular diseas e: a systematic review and meta-analysis. Eur. J. Epidemiol. 27 (2012), 581–591.
82. [82] Sun, Q., Pan, A., Hu, F.B., Manson, J.E., Rexrode, K.M., 25-hydroxyvitamin D levels and the risk of stroke: a prospective study and meta-analysis. Stroke 43 (2012), 1470–1477.
83. [83] Welles, C.C., Whooley, M.A., Karumanchi, S.A., Hod, T., Thadhani, R., Berg, A.H., Ix, J.H., Mukamal, K.J., Vitamin, D., Deficiency and cardiovascular events in patients with coronary heart disease: data from the heart and soul study. Am. J. Epidemiol. 179 (2014), 1279–1287.
84. [84] Schneider, A.L., Lutsey, P.L., Selvin, E., Mosley, T.H., Sharrett, A.R., Carson, K.A., Post, W.S., Pankow, J.S., Folsom, A.R., Gottesman, R.F., Michos, E.D., Vitamin, D., Vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Eur. J. Neurol. 22 (2015), 1220–1227.
85. [85] Michos, E.D., Carson, K.A., Schneider, A.L., Lutsey, P.L., Xing, L., Sharrett, A.R., Alonso, A., Coker, L.H., Gross, M., Post, W., Mosley, T.H., Gottesman, R.F., Vitamin, D., Subclinical cerebrovascular disease: the atherosclerosis risk in communities brain magnetic resonance imaging study. JAMA Neurol. 71 (2014), 863–871.
86. [86] Durup, D., Jørgensen, H.L., Christensen, J., Tjønneland, A., Olsen, A., Halkjær, J., Lind, B., Heegaard, A.M., Schwarz, P.J., Reverse, A., J-shaped association between serum 25-hydroxyvitamin D and cardiovascular disease mortality: the CopD study. Clin. Endocrinol. Metab. 100 (2015), 2339–2346.
87. [87] Daubail, B., Jacquin, A., Guilland, J.C., Khoumri, C., Aboa-Eboulé, C., Giroud, M., Béjot, Y., Association between serum concentration of vitamin D and 1-year mortality in stroke patients. Cerebrovasc. Dis. 37 (2014), 364–367.
88. [88] Daubail, B., Jacquin, A., Guilland, J.C., Hervieu, M., Osseby, G.V., Rouaud, O., Giroud, M., Béjot, Y., Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients. Eur. J. Neurol. 20 (2013), 57–61.
89. [89] Park, K.Y., Chung, P.W., Kim, Y.B., Moon, H.S., Suh, B.C., Won, Y.S., Kim, J.M., Youn, Y.C., Kwon, O.S., Serum Vitamin, D., Status as predictor of prognosis in patients with acute ischemic stroke. Cerebrovasc. Dis. 40 (2015), 73–80.
90. [90] Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N.C., Greenland, P., Heckbert, S.R., Johnson, K.C., Manson, J.E., Sidney, S., Trevisan, M., Women's Health Initiative investigators. Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 (2007), 846–854.
91. [91] Hollis, B.W., Wagner, C.L., Clinical review: the role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J. Clin. Endocrinol. Metab. 98 (2013), 4619–4628.
92. [92] Elamin, M.B., Abu Elnour, N.O., Elamin, K.B., Fatourechi, M.M., Alkatib, A.A., Almandoz, J.P., Liu, H., Lane, M.A., Mullan, R.J., Hazem, A., et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 96 (2011), 1931–1942.
93. [93] Anagnostis, P., Karras, S.N., Athyros, V.G., Annweiler, C., Karagiannis, A., The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes. Lancet Diabetes Endocrinol. 2 (2014), 362–363.